Anastrozole Tops Tamoxifen in Decade-Long Analysis of ATAC Trial - OncologySTAT

Anastrozole Tops Tamoxifen in Decade-Long Analysis of ATAC Trial - OncologySTAT

- Anastrozole remained superior to tamoxifen as an adjuvant treatment for invasive breast cancer in postmenopausal women, based on 10-year follow-up data from the Arimidex, Tamoxifen Alone or in Combination trial known as ATAC